a man looking to the left and slightly smiling

Clinical trials

If you are interested in joining a clinical trial, please explore the links below to understand eligibility criteria and find study locations currently open for enrollment.

atai Life Sciences is conducting clinical trials to evaluate potential new treatments for mental health disorders. These investigational therapies are being studied to assess their safety and effectiveness, with the goal of addressing unmet medical needs.

The compounds being tested in these trials are not yet approved for use. Participation in a clinical trial is an opportunity to contribute to scientific research that may help advance future treatment options.

Trial Name

Study ID

Status

Compound

Location

Information & Eligibility

Trial Name

Elumina: A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Assess the Efficacy, Safety, and Tolerability of Repeated Doses of VLS-01 Buccal Film in Participants With Treatment Resistant Depression

(NCT06524830)

Study ID

VLS-01-203

Status

Actively  Recruiting

Compound

VLS-01

Location

USA (Multiple  Locations)

Information & Eligibility

More information on VLS-01-203

Trial Name

A Phase 2a, Exploratory, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety, Tolerability, and Efficacy of EMP-01 in Adult Participants With Social Anxiety Disorder

(NCT06693609)

Study ID

EMP-01-201

Status

Not yet recruiting

Compound

EMP-01

Location

UK (Multiple Locations)

Information & Eligibility

More information on EMP-01-201

Discover atai news

Stay up to date on atai’s latest news and thoughts.

Press releases Thought leadership Media coverage